文献速递腹部介入PETCT

探讨治疗前18F-FDG PET/CT在预测肝细胞癌病理特征及肝移植后复发中的价值

Investigating the value of pre-treatment 18F-FDG PET/CT in predicting the pathological characteristic of hepatocellular carcinoma and recurrence after liver transplantation.
PubMed 文献 · Abdom Radiol (NY) · 2021-01-02

本研究回顾性纳入34例肝移植前未接受其他治疗并行18F-FDG PET/CT的肝细胞癌患者,计算肿瘤最大标准摄取值(T-SUVmax)及其与正常肝组织(T/L)、纵隔血池(T/B)的比值,结合移植后病理和ROC曲线评估预测病理特征及移植后复发的效能。结果显示治疗前18F-FDG PET/CT对预测肝移植后复发有效,并在预测病理分级、微血管侵犯和肝包膜侵犯方面具有价值。

要点

  • T/B预测肝移植后复发的AUC为0.931,cutoff值2.2,预测准确率88.2%。
  • T-SUVmax、T/L、T/B预测病理分级的AUC分别为0.820、0.784、0.806。
  • T/B预测微血管侵犯和肝包膜侵犯的AUC分别为0.825和0.788。

诊断标准与关键数值

  • T-SUVmax、T/L、T/B预测病理分级的AUC分别为0.820、0.784、0.806。
  • T-SUVmax、T/L、T/B预测肝移植后复发的AUC分别为0.865、0.899、0.931,对应cutoff值分别为5.0、1.7、2.2,预测准确率分别为88.2%、85.3%、88.2%。
  • T/B预测微血管侵犯和肝包膜侵犯的AUC分别为0.825和0.788。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study is to investigate the value of pre-treatment 18F-FDG PET/CT in predicting the pathological characteristic of HCC and recurrence after liver transplantation (LT).

METHODS: A total of 34 patients who underwent 18F-FDG PET/CT before LT for HCC and did not receive any other treatment were retrospectively enrolled in the study. The maximal standard uptake value of the tumor (T-SUVmax), normal liver tissues (L-SUVmax), and mediastinal blood pool (B-SUVmax) were derived, followed by the calculations of the T-SUVmax/L-SUVmax (T/L) and the T-SUVmax/B-SUVmax (T/B) ratios. Combined with the post-transplantation pathological results and ROC curve, the performance in predicting the pathological characteristic and the recurrence after LT were evaluated.

RESULTS: The AUCs for T-SUVmax, T/L, and T/B in predicting the pathological grade of tumors were 0.820, 0.784, and 0.806, respectively. Alternatively, the AUCs for T-SUVmax, T/L, and T/B in predicting the recurrence after LT were 0.865, 0.899, and 0.931, respectively. The individual cutoff values were 5.0, 1.7, and 2.2, corresponding to a predication accuracy of 88.2%, 85.3%, and 88.2%, respectively. In addition, the AUCs for T/B in predicting microvascular invasion (mVI) and liver capsular invasion (LCI) were 0.825 and 0.788, respectively.

CONCLUSION: The pre-treatment 18F-FDG PET/CT is effective for predicting recurrence of HCC after LT. In addition, it demonstrates values for predicting the pathological characteristic of HCC such as pathological grade, mVI, and LCI.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Lv J, Yin H, Mao W, et al. Investigating the value of pre-treatment 18F-FDG PET/CT in predicting the pathological characteristic of hepatocellular carcinoma and recurrence after liver transplantation. Abdom Radiol (NY). 2021. PMID: 33386905. doi:10.1007/s00261-020-02872-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。